doi:10.48130/ejcc-0026-0006

[1]

Elmadani M, Mokaya PO, Omer AAA, Kiptulon EK, Klara S, et al. 2025. Cancer burden in Europe: a systematic analysis of the GLOBOCAN database (2022). BMC Cancer 25:447

doi: 10.1186/s12885-025-13862-1

[2]

Boubaddi M, Rossi J, Marichez A, Marty M, Amintas S, et al. 2025. Preoperative prognostic factors in resectable pancreatic cancer: state of the art and prospects. Annals of Surgical Oncology 32:4117−4127

doi: 10.1245/s10434-025-17062-w

[3]

Cao Y, Zhao R, Guo K, Ren S, Zhang Y, et al. 2022. Potential metabolite biomarkers for early detection of stage-I pancreatic ductal adenocarcinoma. Frontiers in Oncology 11:744667

doi: 10.3389/fonc.2021.744667

[4]

Guo K, Ren S, Zhang H, Cao Y, Zhao Y, et al. 2023. Biomimetic gold nanorods modified with erythrocyte membranes for imaging-guided photothermal/gene synergistic therapy. ACS Applied Materials & Interfaces 15:25285−25299

doi: 10.1021/acsami.3c00865

[5]

Neoptolemos JP, Palmer DH, Ghaneh P, Psarelli EE, Valle JW, et al. 2017. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. The Lancet 389:1011−1024

doi: 10.1016/S0140-6736(16)32409-6

[6]

Kristensen A, Vagnildhaug OM, Grønberg BH, Kaasa S, Laird B, et al. 2016. Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review. Critical Reviews in Oncology/Hematology 99:286−298

doi: 10.1016/j.critrevonc.2016.01.006

[7]

Burrell S, Yeo T, Smeltzer S, Leiby B, Lavu H, et al. 2018. Symptom clusters in patients with pancreatic cancer undergoing surgical resection: part I. Oncology Nursing Forum 45:E36−E52

doi: 10.1188/18.ONF.E36-E52

[8]

Seelen LWF, Augustinus S, Stoop TF, Bouwense SAW, Busch OR, et al. 2025. Quality of life among patients with locally advanced pancreatic cancer: a prospective nationwide multicenter study. Journal of the National Comprehensive Cancer Network 23:97−104

doi: 10.6004/jnccn.2024.7091

[9]

Ploukou S, Papakosta-Gaki E, Panagopoulou E, Benos A, Smyrnakis E. 2024. Unmet needs in the process of chemotherapy provision in pancreatic cancer patients from the healthcare provider perspective: a phenomenological study in Greece. Slovenian Journal of Public Health 63:73−80

doi: 10.2478/sjph-2024-0011

[10]

Cass SH, Williams LA, Rajaram R, Hirata Y, Rice D, et al. 2024. Patient-reported outcome measures in surgical patients with upper gastrointestinal cancers: a qualitative interview study. Journal of Surgical Oncology 130:117−124

doi: 10.1002/jso.27687

[11]

Potiaumpai M, Schleicher EA, Wang M, Campbell KL, Sturgeon K, et al. 2023. Exercise during chemotherapy: friend or foe? Cancer Medicine 12:10715−10724

doi: 10.1002/cam4.5831

[12]

Dodd MJ, Miaskowski C, Paul SM. 2001. Symptom clusters and their effect on the functional status of patients with cancer. Oncology Nursing Forum 28:465−470

[13]

Yang Y. 2020. Study on the status of symptom burden and its influencing factors in patients with pancreatic cancer. Master's Thesis. Shanghai University of Traditional Chinese Medicine. http://doi.org/10.27320/d.cnki.gszyu.2020.000886 (in Chinese)

[14]

Olsson C, Larsson M. 2024. Evidence-based and person-centered symptom cluster management in cancer care: the value of symptom theory. Cancer Nursing 47:423−424

doi: 10.1097/NCC.0000000000001406

[15]

Lenz ER, Pugh LC, Milligan RA, Gift A, Suppe F. 1997. The middle-range theory of unpleasant symptoms: an update. ANS Advances in Nursing Science 19:14−27

doi: 10.1097/00012272-199703000-00003

[16]

Fu L, Feng X, Jin Y, Lu Z, Li R, et al. 2022. Symptom clusters and quality of life in gastric cancer patients receiving chemotherapy. Journal of Pain and Symptom Management 63:230−243

doi: 10.1016/j.jpainsymman.2021.09.003

[17]

Lin DM, Yin XX, Wang N, Zheng W, Wen YP, et al. 2019. Consensus in identification and stability of symptom clusters using different symptom dimensions in newly diagnosed acute myeloid leukemia patients undergoing induction therapy. Journal of Pain and Symptom Management 57:783−792

doi: 10.1016/j.jpainsymman.2018.12.329

[18]

Zhang G, Weng H, Li Y, Li P, Gong Y, et al. 2022. Symptom clusters and their predictors in patients with lung cancer and treated with programmed cell death protein 1 immunotherapy. Asia-Pacific Journal of Oncology Nursing 9:100103

doi: 10.1016/j.apjon.2022.100103

[19]

Mao D, Luo Y, Zhang L, Zhu B, Yang Z, et al. 2025. Status and influencing factors of fatigue-pain-sleep disturbance symptom cluster in patients with lung cancer: a latent profile analysis. Research in Nursing & Health 48:626−639

doi: 10.1002/nur.70011

[20]

Liang M, Li J, Xiang J, Zeng Y, Li S, et al. 2025. Contemporaneous and temporal symptom drivers during breast cancer chemotherapy: a prospective repeated-measures cohort study. European Journal of Oncology Nursing 78:102944

doi: 10.1016/j.ejon.2025.102944

[21]

Reyes-Gibby CC, Chan W, Abbruzzese JL, Xiong HQ, Ho L, et al. 2007. Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation. Journal of Pain and Symptom Management 34:244−252

doi: 10.1016/j.jpainsymman.2006.11.007

[22]

Sapnas KG, Zeller RA. 2002. Minimizing sample size when using exploratory factor analysis for measurement. Journal of Nursing Measurement 10:135−154

doi: 10.1891/jnum.10.2.135.52552

[23]

Portenoy RK, Thaler HT, Kornblith AB, McCarthy Lepore J, Friedlander-Klar H, et al. 1994. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. European Journal of Cancer 30:1326−1336

doi: 10.1016/0959-8049(94)90182-1

[24]

Cheng KKF, Wong EMC, Ling WM, Chan CWH, Thompson DR. 2009. Measuring the symptom experience of Chinese cancer patients: a validation of the Chinese version of the memorial symptom assessment scale. Journal of Pain and Symptom Management 37:44−57

doi: 10.1016/j.jpainsymman.2007.12.019

[25]

Kondrup J, Allison SP, Elia M, Vellas B, Plauth M. 2003. ESPEN guidelines for nutrition screening 2002. Clinical Nutrition 22:415−421

doi: 10.1016/s0261-5614(03)00098-0

[26]

Chen W, Jiang ZM, Zhang YM, Wang XR, Chen CM, et al. 2005. 欧洲营养不良风险调查方法在中国住院患者的临床可行性研究 [Evaluation of European Nutritional Risk Screening method in Chinese hospitalized patients practice]. 中国临床营养杂志 [Chinese Journal of Clinical Nutrition] 13:137−141 (in Chinese)

[27]

Crooks V, Waller S, Smith T, Hahn TJ. 1991. The use of the karnofsky performance scale in determining outcomes and risk in geriatric outpatients. Journal of Gerontology 46:M139−M144

doi: 10.1093/geronj/46.4.m139

[28]

Kim E, Jahan T, Aouizerat BE, Dodd MJ, Cooper BA, et al. 2009. Changes in symptom clusters in patients undergoing radiation therapy. Supportive Care in Cancer 17:1383−1391

doi: 10.1007/s00520-009-0595-5

[29]

He J, Feng LN, Tian JL, Zhu XM, Xu XT. 2025. The changes of core symptoms and nursing implications for lymphoma patients with chemotherapy. Chinese Journal of Nursing 60:2492−2498

[30]

Li W, Xu YH, Wang JN, Hong SS, Yang ZC, et al. 2025. 胰腺癌病人术后真实体验质性研究的 Meta 整合 [Qualitative study on the real experience of pancreatic cancer patients after surgery: a Meta-integration]. 循证护理 [Chinese Evidence-Based Nursing] 11:210−216 (in Chinese)

doi: 10.12102/j.issn.2095-8668.2025.02.004

[31]

Hu Y, Duan PB, Hou QM, Wang X. 2017. 胃癌术后化疗患者症状严重度与困扰度调查研究 [Symptom severity and distress in patients with gastric cancer undergoing chemotherapy]. 护理学杂志 [Journal of Nursing Science] 32:18−21 (in Chinese)

doi: 10.3870/j.issn.1001-4152.2017.20.018

[32]

Wang K, Diao M, Yang Z, Salvador JT, Zhang Y. 2025. Identification of core symptom cluster in patients with digestive cancer: a network analysis. Cancer Nursing 48:E55−E63

doi: 10.1097/NCC.0000000000001280

[33]

Ju X, Bai J, She Y, Zheng R, Xu X, et al. 2023. Symptom cluster trajectories and sentinel symptoms during the first cycle of chemotherapy in patients with lung cancer. European Journal of Oncology Nursing 63:102282

doi: 10.1016/j.ejon.2023.102282

[34]

Whitcomb DC, Buchner AM, Forsmark CE. 2023. AGA clinical practice update on the epidemiology, evaluation, and management of exocrine pancreatic insufficiency: expert review. Gastroenterology 165:1292−1301

doi: 10.1053/j.gastro.2023.07.007

[35]

Lopes-Júnior LC, Grassi J, Freitas MB, Trigo FES, Aguilar Jardim F, et al. 2025. Cancer symptom clusters in children and adolescents with cancer undergoing chemotherapy: a systematic review. Nursing Reports 15:163

doi: 10.3390/nursrep15050163

[36]

Li R, Ma J, Chan Y, Yang Q, Zhang C. 2020. Symptom clusters and influencing factors in children with acute leukemia during chemotherapy. Cancer Nursing 43:411−418

doi: 10.1097/NCC.0000000000000716

[37]

Sonis ST. 2004. The pathobiology of mucositis. Nature Reviews Cancer 4:277−284

doi: 10.1038/NRC1318

[38]

Fang Z, Li J, Xiong Y, Luo P, Lu Q, et al. 2025. FBXL16 regulates TAMs recruitment by mediating cytokine release in gliomas. Cancer Genetics 298:285−294

doi: 10.1016/j.cancergen.2025.11.006

[39]

Wei L, Lv F, Luo C, Fang Y. 2023. Study on sentinel symptoms and influencing factors of postoperative chemotherapy in patients with gastric cancer. European Journal of Oncology Nursing 64:102318

doi: 10.1016/j.ejon.2023.102318

[40]

Shi XH. 2022. 胶质瘤患者化疗期间症状群的影响因素及其对生活质量的影响 [Influencing factors of symptom clusters and their effects on quality of life in patients with glioma during chemotherapy]. Master's thesis. Shandong University, Jinan, China. doi: 10.27272/d.cnki.gshdu.2022.001028 (in Chinese)

[41]

Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, et al. 2017. ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition 36:11−48

doi: 10.1016/j.clnu.2016.07.015

[42]

Hao Y, Wu H, Huang Y. 2025. Symptom clusters in patients with brain tumors: a systematic review. Seminars in Oncology Nursing 41:151815

doi: 10.1016/j.soncn.2025.151815

[43]

Harris CS, Kober KM, Conley YP, Dhruva AA, Hammer MJ, et al. 2022. Symptom clusters in patients receiving chemotherapy: a systematic review. BMJ Supportive & Palliative Care 12:10−21

doi: 10.1136/bmjspcare-2021-003325

[44]

Ma JS, Xu H, Liu S, Wang AP. 2022. 肺癌术后病人化疗初期症状群内前哨症状的调查[Investigation of sentinel symptoms in the initial symptom group of patients with lung cancer after chemotherapy]. 护理研究 [Chinese Nursing Research] 36:3528−3533 (in Chinese)

doi: 10.12102/j.issn.1009-6493.2022.19.029

[45]

Tie H, Shi L, Wang L, Hao X, Fang H, et al. 2023. Symptom clusters and characteristics of cervical cancer patients receiving concurrent chemoradiotherapy: a cross-sectional study. Heliyon 9:e22407

doi: 10.1016/j.heliyon.2023.e22407

[46]

Burger JA, Okkenhaug K. 2014. Idelalisib − targeting PI3Kδ in patients with B-cell malignancies. Nature Reviews Clinical Oncology 11:184−186

doi: 10.1038/nrclinonc.2014.42

[47]

Hong Y, Yang Z, Luo N, Busschbach J. 2026. Anxiety and depression may amplify self-reported physical health problems: evidence from EQ-5D-5L data. Health and Quality of Life Outcomes 24:45

doi: 10.1186/s12955-026-02497-w

[48]

Chen DD, Qiao TT, Zheng W, Zhang W, Wang ZG, et al. 2016. 胃肠道肿瘤患者首次辅助化疗后症状群的调查研究 [Symptom clusters of patients with gastroenteric tumor after first adjuvant chemotherapy]. 中国全科医学 [Chinese General Practice] 19:3215−3218 (in Chinese)

doi: 10.3969/j.issn.1007-9572.2016.26.017

[49]

Lai Y, Qiu G, Zheng Z, Huang X, Guo P, et al. 2026. Platinum accumulation in chemotherapy: toxicity mechanisms, challenges, and mitigation strategies. BioMetals 2026:1−21

doi: 10.1007/s10534-026-00812-y

[50]

Singh SB, Bhandari S, Siwakoti S, Kumar M, Singh R, et al. 2024. PET/CT in the evaluation of CAR-T cell immunotherapy in hematological malignancies. Molecular Imaging 23:15353508241257924

doi: 10.1177/15353508241257924

[51]

Ma HY, Zheng DL, Guo SP, Mao YJ, Wang HR, et al. 2023. Investigation of symptom clusters recognition and its influencing factors in patients after coronary artery bypass grafting. Chinese Journal of Nursing 58:158−164

doi: 10.3761/j.issn.0254-1769.2023.02.004

[52]

Liao H, Ma Q, Chen L, Guo W, Feng K, et al. 2025. Machine learning analysis of CD4+ T cell gene expression in diverse diseases: insights from cancer, metabolic, respiratory, and digestive disorders. Cancer Genetics 290:56−60

doi: 10.1016/j.cancergen.2024.12.004

[53]

Sørensen LT, Jørgensen S, Petersen LJ, Hemmingsen U, Bülow J, et al. 2009. Acute effects of nicotine and smoking on blood flow, tissue oxygen, and aerobe metabolism of the skin and subcutis. Journal of Surgical Research 152:224−230

doi: 10.1016/j.jss.2008.02.066

[54]

Luo Y, Luo J, Su Q, Yang Z, Miao J, et al. 2024. Exploring central and bridge symptoms in patients with lung cancer: a network analysis. Seminars in Oncology Nursing 40:151651

doi: 10.1016/j.soncn.2024.151651

[55]

Zhang W, Wang WL, Zhang XQ. 2016. 化疗期消化道癌症患者症状群及影响因素研究 [Symptom clusters of patients with digestive tract cancers undergoing chemotherapy and the influencing factors]. 中国全科医学 [Chinese General Practice] 19:59−62,77 (in Chinese)

doi: 10.3969/j.issn.1007-9572.2016.01.011

[56]

Mellion M, Gilchrist JM, De La Monte S. 2011. Alcohol-related peripheral neuropathy: nutritional, toxic, or both? Muscle & Nerve 43:309−316

doi: 10.1002/mus.21946

[57]

Huang J, Gu L, Zhang L, Lu X, Zhuang W, et al. 2016. Symptom clusters in ovarian cancer patients with chemotherapy after surgery: a longitudinal survey. Cancer Nursing 39:106−116

doi: 10.1097/NCC.0000000000000252

[58]

Nozawa K, Toma S, Shimizu C. 2023. Distress and impacts on daily life from appearance changes due to cancer treatment: a survey of 1, 034 patients in Japan. Global Health & Medicine 5:54−61

doi: 10.35772/ghm.2022.01062

[59]

Ma DY, Rong XX, Su CY, Tong JJ, Hong SK, et al. 2025. 恶性肿瘤患者化疗相关症状群的共性影响因素 [Common influences on chemotherapy-related symptom clusters in cancer patients]. 中华疾病控制杂志 [Chinese Journal of Disease Control and Prevention] 29:487−491 (in Chinese)

doi: 10.16462/j.cnki.zhjbkz.2025.04.018

[60]

Fang J, Wong CL, Liu CQ, Huang HY, Qi YS, et al. 2023. Identifying central symptom clusters and correlates in children with acute leukemia undergoing chemotherapy: a network analysis. Frontiers in Oncology 13:1236129

doi: 10.3389/fonc.2023.1236129